Drug intelligence / Profile preview

2-ethoxyethyl (2S,3S)-4-((S)-2-benzyl-3-oxo-4-((3aR,8R,8aS)-2-oxo-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-8-yl)-2,3-dihydro-1H-pyrrol-2-yl)-3-hydroxy-1-phenylbutan-2-carbamate

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a synthetic small molecule with the molecular formula C36H39N3O7 and a molecular weight of approximately 625.7 g/mol[1][9]. It is listed in chemical databases such as PubChem (CID:5459358) and DrugBank (DB04623), where it is classified as an experimental drug belonging to the class of amphetamines and derivatives[1][2]. There is no publicly available information on its mechanism of action or therapeutic indication; it appears to be primarily a research compound with no established clinical use or approved medical application at this time[1][9]. No data are available regarding its pharmacology or biological targets.

Other names: 2-Ethoxyethyl (2S,3S)-4-((S)-2-benzyl-3-oxo-4-((3aR,8R,8aS)-2-oxo-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-8-yl)–2.3–dihydro–1H-pyrrol––(alt. stereochemistry and minor naming variants)2-Ethoxyethyl N-[...carbamate] (see PubChem/DrugBank for full IUPAC variants)[1][9]

Beyond the preview

Go deeper on 2-ethoxyethyl (2S,3S)-4-((S)-2-benzyl-3-oxo-4-((3aR,8R,8aS)-2-oxo-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-8-yl)-2,3-dihydro-1H-pyrrol-2-yl)-3-hydroxy-1-phenylbutan-2-carbamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-ethoxyethyl (2S,3S)-4-((S)-2-benzyl-3-oxo-4-((3aR,8R,8aS)-2-oxo-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-8-yl)-2,3-dihydro-1H-pyrrol-2-yl)-3-hydroxy-1-phenylbutan-2-carbamate.

Explore the full profile